HOME >> BIOLOGY >> NEWS
Leader in cancer treatment and prevention research honored

PHILADELPHIA David S. Alberts, M.D., Regents Professor of Medicine, Pharmacology, Nutritional Science, and Public Health at the University of Arizona College of Medicine, and Director of the Cancer Prevention and Control Program at the Arizona Cancer Center, Tucson, is the recipient of the 2004 American Association for Cancer Research (AACR)-Cancer Research and Prevention Foundation (CRPF) Award for Excellence in Cancer Prevention Research. He is among the first in cancer research to begin studying in the laboratory those basic chemical agents and nutrients with the potential to treat or prevent cancer, and then to take them through pharmacological development and on to clinical trials in patients.

"Dr. Alberts is a true pioneer in translational cancer prevention research," said Margaret Foti, Ph.D., M.D. (h.c.), AACR chief executive officer.

"His many contributions to the field have advanced cancer prevention from its earliest preclinical and clinical stages of drug development to definitive, randomized controlled trials. His laboratory and clinical research has emphasized the chemoprevention and treatment of such pervasive and potentially deadly diseases as breast, colon, ovarian, and skin cancer."

Beginning in the 1970s, Dr. Alberts conducted landmark studies on the analytical chemistry and pharmacokinetics of retinoids derived from Vitamin A. Results of clinical trials in more than 2,200 patients led to the finding that retinol is effective in preventing squamous cell skin cancer. Following this work, he developed a panel of biomarkers of skin carcinogenesis, including proliferating cell nuclear antigen (PCNA), p53, polyamine levels, and apoptosis. Together with his research group, the Chemoprevention of Skin Cancer Program Project, he developed topically administered chemopreventive agents that can be incorporated into sunscreens.

Dr. Alberts also published an important study which rejected the hypothesis that dietary supple
'"/>

Contact: Sheri Ozard
ozard@aacr.org
215-440-9300
American Association for Cancer Research
30-Sep-2004


Page: 1 2 3

Related biology news :

1. 20 scientists selected as Aldo Leopold Leadership Fellows
2. Dr. Gonsalves will receive ASPB Leadership in Science Public Service Award
3. National Laboratory, National Parks And Forests Leaders Seek To Share Resources
4. Aldo Leopold Leadership Program Selects First Cohort
5. Online Briefings At AAAS To Feature New Research On Oceans; Discussion With Leaders Of Large Hadron Collider And International Space Station
6. Angry Biotech Firms Are Blaming The Industry Leader For Bringing Modified Crops Into Disrepute
7. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
8. Chemical derived from vitamin-E shows early promise as cancer drug
9. New molecular link key to cellular proteins involved in cancer progression, other diseases
10. Phase II trials of second-generation antisense cancer drug planned following successful early study
11. Trial shows which brain cancer patients benefit from temozolomide

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 16, 2019 , ... uBiome, the leader in microbial ... uses artificial intelligence (AI) and a data-centric approach to decentralize medicine using blockchain ... , People will Crohn’s or other chronic medical conditions join a relevant study ...
(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
(Date:1/10/2019)... , ... January 10, 2019 , ... ... the translational gap between inexpensive in vitro studies and significantly more expensive in ... in vivo efficacy and toxicity. To address this need, researchers have begun to ...
Breaking Biology News(10 mins):
(Date:2/12/2019)... SAN FRANCISCO (PRWEB) , ... February 12, 2019 ... ... (CRO) specializing in dermatology, has finalized a deal to extend their use of ... diagnostics clinical trials, through 2023. The CRO has been a regular Medrio customer ...
(Date:2/2/2019)... ... February 01, 2019 , ... Biomatlante, a ... of its new CEO, Julien Dert, being effective on February 1st, 2019. , ... finance and management, in which more than 12 years in the Medical Device ...
(Date:1/30/2019)... ... January 29, 2019 , ... K&R Negotiations announced today that Mladen ... special online event titled: Six Ways to Shorten the Sales Cycle : Reduce ... 2019 on the BrightTALK network. , Negotiation expert Kresic will discuss the realities ...
(Date:1/28/2019)... ... January 28, 2019 , ... ... low molecular weight compounds. In this early stage, false positives can be problematic ... time, it is vital that screening techniques are highly sensitive to detect weak ...
Breaking Biology Technology:
Cached News: